‘Senolytic’ Therapy Shows Promise in Neovascular Eye Disease
MedPage Today) — NEW YORK CITY — An investigational drug targeting senescent cells achieved sustained improvement in visual acuity in patients with diabetic macular edema (DME) or neovascular age-related macular…